Allevion Medical™ Secures 510(k) Clearance for Vantage™, an Innovative Fully Disposable System Designed for Advanced Spinal Decompression Allevion Medical has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its latest innovation, Vantage™, a…
Coya Therapeutics Details Upcoming Board Transition, Names Mark H. Pavao as Independent Director Coya Therapeutics, Inc., a clinical-stage biotechnology company focused on developing innovative biologic therapies designed to enhance regulatory T cell (Treg) function in patients with neurodegenerative diseases, has…
Feinstein Institutes Honors Drs. Michel Sadelain and Carl H. June with the 2026 Ross Prize in Molecular Medicine The Feinstein Institutes for Medical Research has announced that two pioneers of modern cancer immunotherapy—Carl H. June, MD, of the University of…
INLEXZO™ (gemcitabine intravesical system) Receives Permanent Billing Code to Enhance Access for Select Bladder Cancer Patients Johnson & Johnson has announced a key reimbursement milestone for its bladder cancer therapy INLEXZO, with the assignment of a permanent Healthcare Common Procedure…
Agilent Introduces the BioTek Cytation 9 Cell Imaging Multimode Reader Agilent Technologies, Inc. has announced the launch of its latest innovation in laboratory instrumentation, the BioTek Cytation 9 cell imaging multimode reader, expanding its Cytation portfolio with a next-generation platform…
Janux Therapeutics Confirms Candidate Nomination in Bristol Myers Squibb Partnership, Activating $35 Million Milestone Payment Janux Therapeutics, Inc. has announced a significant milestone under its strategic collaboration with Bristol Myers Squibb, marking continued progress in the development of next-generation immunotherapies.…
FORE Biotherapeutics Earns Breakthrough Therapy Designation for Plixorafenib FORE Biotherapeutics, a registration-stage biopharmaceutical company focused on developing precision therapies for cancer, has announced a significant regulatory milestone for its lead investigational therapy. The U.S. Food and Drug Administration has granted…
VDYNE Secures FDA IDE Clearance to Launch TRIVITA1 Pivotal Trial for Its Transcatheter Tricuspid Valve Replacement System VDYNE, Inc., a privately held medical device innovator focused on advancing next-generation structural heart therapies, has announced a major regulatory milestone with the…
Biogen’s Acquisition of Apellis Strengthens Immunology and Rare Disease Portfolio While Accelerating Growth and Entry into Nephrology Biogen Inc. and Apellis Pharmaceuticals (Nasdaq: APLS) have announced a definitive agreement under which Biogen will acquire Apellis in a transaction valued at…
Submissions Open for the Second Annual Thomas J. Fogarty Prize Recognizing Breakthrough Medtech Innovations Nominations are set to open on April 2, 2026, for the second annual Thomas J. Fogarty Innovation Prize, widely regarded as one of the most prestigious…
Bayer Implements U.S. Leadership Restructuring in Pharmaceuticals’ Worldwide Markets to Accelerate Growth Potential Bayer has announced a significant leadership transition within its Pharmaceuticals division, signaling a strategic move to accelerate growth and strengthen its position in the United States—one of…
Tanner Pharma Group and Biodexa Introduce Global Early Access Initiative for Patients with Familial Adenomatous Polyposis (FAP) Tanner Pharma Group, a globally recognized provider of specialty medicine access solutions, has entered into a strategic partnership with Biodexa Pharmaceuticals PLC, a…